The Qualitative detection of Hepatitis B virus “e” antigen (HBeAg) and Hepatitis B virus “e” antibody (HBeAb) in human sera by the FDA approved LIASON® IgG Assay.
The presence of HBeAg in serum is associated with presence of Dane particles and Hepatitis B virus (HBV) DNA polymerase enzyme. These markers suggest active HBV replication. Hepatitis B Surface antigen (HBsAg) positive and HBeAg positive persons are much more likely to transmit infections to others. The development of anti-HBe during acute Hepatitis B infection is a marker of resolution of illness.
Code | Name |
---|---|
HEAG | Hepatitis B e Ag |
HEAB | Hepatitis B e Ab |
IN3 | Hepatitis B e Ag and Ab Interp |
The qualitative determination of HBeAg is a direct, sandwich chemiluminescence immunoassay (CLIA). The qualitative determination of anti-HBe is a competitive sandwich chemiluminescence immunoassay (CLIA) based on neutralization.
Blood: 5 mL blood in GOLD TOP serum separator tube (SST).
Also acceptable: 5 mL blood in ORANGE TOP rapid serum tube (RST), RED TOP tube or the following anticoagulants EDTA, heparin, or citrate.
Blood: Harvest serum/plasma from whole blood within 24 hour or collection. Serum/plasma may be stored at 2-8°C (ice pack) for up to 3 days at room temperature (15-30°C) or up to 7 days. Freeze at -20°C or colder for long term storage. Do not freeze/thaw.
Outside Laboratories: Ship samples on Dry Ice, do not freeze/thaw. If freezer and/or dry ice is not available, ship immediately at 2-8°C (ice pack), shipment time must not to exceed 7 days from collection. Samples stored at 2-8°C greater than 7 days old will be rejected.
Unacceptable samples: Cord blood, neonatal specimens, cadaver specimens, heat-inactivated specimens, or body fluids such as saliva, urine, amniotic fluid, or pleural fluid. Specimens with obvious microbial contamination, lipemic or are grossly hemolyzed.
Other |
Virology
206-685-8037 Virology Laboratory, Ste 320 |
---|